Free shipping over $99. Shop Now.

Cannabis testing is required for safety

Medical marijuana isn’t always as advertised—at least not in the Seattle area, as one lab found out.The lab, Analytical 360, recently worked with medical-marijuana patient Jessica Tonani to test samples from 22 area dispensaries and growers, The Seattle Times reports. The samples were all supposed to be of a strain of marijuana called Harlequin that has low levels of intoxicating chemicals, but high levels of therapeutic ones. Instead, five of the samples were the opposite. They were high in psychedelic tetrahydrocannabinol (THC), but had “virtually no” cannabidiol, which medical-marijuana users seek to help with the symptoms of epilepsy, inflammatory bowel disease and other diseases.

As more states have legalized medical and recreational marijuana use, there’s been growing interest in making sure pot products are clean and consistent and offer customers the effects they want. It’s just like any other commercial product, from ibuprofen to Greek yogurt. Last year, Chemical & Engineering Newsreported on small commercial labs, including Analytical 360, that had popped up to offer marijuana chemistry-testing services. “Why should medical marijuana be different from any other pharmaceutical?” C&EN asked, rhetorically. Before that, Slate published a story that included the reporter’s brother, a scientist for a commercial lab who helps breeders and dispensaries determine the strength and quality—no mites or mold, please—of their stuff.

So the infrastructure for maintaining quality control in commercially sold marijuana is there. But the new Seattle Times report shows not every dispensary is testing its products, or heeding the results of tests. Consumer demand for more consistent products may push dispensaries to shape up. So might stricter laws. The Times points to the state government of Connecticut, which doesn’t allow marijuana growers to give plants certain names, such as Harlequin, unless those plants meet certain chemical profiles.

Designed for Kersten Gaba's mom Basic Jane was deisgned to help arthritis in Joanne's knees
Basic Jane was designed to help Joanne with arthritis using CBD and menthol to help decrease pain and discomfort
Testing CBD produts using HPLC in the Basic Jane lab in partnership with Agilent Technologies

The idea for basic jane

The idea for Basic Jane was founded in 2014, when Jessica and Kersten were approached by Kersten’s 80 year old mother about whether their research company, Verda Bio, could develop anything for her chronic arthritis pain. A few months later our “RELIEVE” formula was born and introduced to the public in 2017.

Since then, our goal has been simple - to make products that we are proud to recommend and have used by our families and friends. We harness the power and simplicity of ”nature" to help deliver hours of pain relief, in a rich all natural formula.

Research Drives Us

Basic Jane is Powered By Verda Bio

Verda Bio is a premier cannabinoid research company. Verda Bio uses a combination of genomic and analytical data to research these amazing compounds. Our breeding program is the cornerstone. Creating stable hemp varieties with unique profiles enables us to formulate the products of the future. Our goal is to create products that consistently meet the needs of consumers.